Can recurrence of meningiomas be predicted?

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2319-2324

  Kalala, Jean Pierre ^a   Benoit, Dominique ^a   De Ridder, Leo ^b,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Department of Histology ^*  (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Confrontation culture; Meningiomas; Proliferation markers

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NERVE CELL CULTURE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL COMMUNICATION; CELL DIVISION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 4444251703     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kleihues P and Cavenee WK: Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumours Lyon 2000.
2. Gerdes J, Schwab U, Lemke H and Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20, 1983.
3. Bravo R, Frank R, Blundell PA and Mac Donald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 326: 515-517, 1987.
4. Mareel M, Kint J and Meyvisch C: Methods of study of invasion in malignant C3H mouse fibroblasts into embryonic chick heart in vitro. Virchows Arch B Cell Path 30: 95-111, 1979.
5. de Ridder L: Spheroides et cultures en agrégats. In: Barlovatz-Meimon G, Adolphe M (eds): Culture de Cellules Animales Méthodologies - Application. Paris: Inserm 2003, pp 95-110.
6. de Ridder L and Calliauw L: Invasiveness of primary and secondary brain tumors in vitro correlated with clinical results. Neurosurgery 31: 1043-1047, 1992.
7. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20: 22-39, 1957.
8. Abramovich CM and Prayson RA: Histopathologic features and MIB labelling indices in recurrent and non recurrent meningiomas. Arch Pathol Lab Med 123: 793-800, 1999.
9. Perry AB, Stafford S, Scheithauer BW, Suman VJ and Lohse CM: Meningioma grading: analysis of histologic parameters. Am J Surg Pathol 21: 1455-1465, 1997.
10. de Ridder L, Cornellissen M and de Ridder D: Autologous spheroid culture: a screening tool for human brain tumour invasion. Crit Rev Oncol/Hematol 36: 107-122, 2000.
11. Jellinger K and Slovik F: Histologic subtypes and prognostic problems in meningiomas. J Neurol 208: 279-298, 1975.
12. May PL, Broome JC Lawry J, Buxton RA and Battersby RDE: The prediction of recurrence in meningiomas. J Neurosurg 71: 347-351, 1989.
13. Philippon J and Cornu P: In: Al-Mefty O (ed): Meningiomas, New York: Raven Press 1991 pp 87-105.
14. Khoshyomn S, Lew S, DeMattia J, Singer EB and Penar PL: Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression. J Neurooncol 45: 111-6, 1999.
15. Akeyson EW and Mc Cutcheon IE: Management of benign and aggressive intracranial meningiomas. Oncology 10: 1-22, 1996.
16. Mahmood A, Qureshi NH and Malik GM: Intracranial meningiomas: analysis of recurrence after surgical treatment. Acta Neurochirurgica 126: 53-58, 1994.